$MSSA
Metal Sky Star Acquisition Corp Stock $mssa

$mssa Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224034449 Filed on August 30, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$161.8K	$200.5K	$798.5K
YoY Change	-38.57%	72.03%	100.22%
Operating Profit			-$798.5K
YoY Change			100.22%
Interest Expense	$458.8K	$628.3K	$2.951M
YoY Change	-46.58%	-36.7%	76.32%
% of Operating Profit
Other Income/Expense, Net	$458.8K		$2.951M
YoY Change	-46.58%		76.32%
Pretax Income	$297.0K	$427.9K	$2.152M
YoY Change	-50.12%	-51.16%	68.84%
Income Tax
% Of Pretax Income
Net Earnings	$297.0K	-$4.691M	$2.152M
YoY Change	-50.12%	-635.38%	68.84%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.05	-$0.64	-$0.34
COMMON SHARES
Basic Shares Outstanding	6.407M shares	6.407M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$0.00
Short-Term Investments
Other Short-Term Assets		$1.880K	$1.880K
YoY Change		-99.14%	-99.14%
Inventory
Prepaid Expenses	$600.00	$1.875K
Receivables
Other Receivables
Total Short-Term Assets	$600.00	$1.875K	$1.880K
YoY Change	-100.0%	-100.0%	-100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$35.36M	$35.36M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$36.07M	$35.36M	$35.36M
YoY Change	-3606792800.0%
TOTAL ASSETS
Total Short-Term Assets	$600.00	$1.875K	$1.880K
Total Long-Term Assets	$36.07M	$35.36M	$35.36M
Total Assets	$36.07M	$35.36M	$35.36M
YoY Change	-38.17%	-69.75%	-69.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$404.8K	$298.3K	$298.3K
YoY Change	40.01%	103.27%	103.27%
Deferred Revenue
YoY Change
Short-Term Debt		$2.172M	$2.172M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.257M	$2.847M	$2.847M
YoY Change	-17.7%	-5.8%	-5.8%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$2.875M	$2.875M
YoY Change
Total Long-Term Liabilities	$2.875M	$2.875M	$2.875M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.257M	$2.847M	$2.847M
Total Long-Term Liabilities	$2.875M	$2.875M	$2.875M
Total Liabilities	$6.132M	$5.722M	$5.722M
YoY Change	54.94%	89.35%	89.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.085M	-$5.773M
YoY Change	58.96%	105.69%
Common Stock	$3.205K	$3.205K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.081M	-$5.770M	$29.64M
YoY Change
Total Liabilities & Shareholders Equity	$36.07M	$35.36M	$35.36M
YoY Change	-38.17%	-69.75%	-69.75%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$297.0K	-$4.691M	$2.152M
YoY Change	-50.12%	-635.38%	68.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		$189.5K	-$233.3K
YoY Change		-2043.79%	166.4%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$250.0K	$26.06M	$84.27M
YoY Change	-100.42%		-173.27%
Cash From Investing Activities	-$250.0K	$26.06M	$84.27M
YoY Change	-100.42%		-173.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$86.38M
YoY Change			-24.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$250.0K	-26.25M	-$84.21M
YoY Change	-100.42%		-173.12%
NET CHANGE
Cash From Operating Activities		189.5K	-$233.3K
Cash From Investing Activities	-$250.0K	26.06M	$84.27M
Cash From Financing Activities	$250.0K	-26.25M	-$84.21M
Net Change In Cash		-1.160K	-$178.7K
YoY Change		-88.1%	-316.09%
FREE CASH FLOW
Cash From Operating Activities		$189.5K	-$233.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001882464
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2022Q4	MSSA	Due To Sponsor DueToSponsor		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges		usd
CY2022	MSSA	Increase Decrease In Due To Sponsor IncreaseDecreaseInDueToSponsor		usd
CY2023	MSSA	Increase Decrease In Accrued Offering Costs IncreaseDecreaseInAccruedOfferingCosts		usd
CY2022	MSSA	Cash Withdrawn From Trust Account To Redeem Public Shares CashWithdrawnFromTrustAccountToRedeemPublicShares		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023	MSSA	Proceeds From Sale Of Units ProceedsFromSaleOfUnits		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2023	MSSA	Defer Underwriting Compensation DeferUnderwritingCompensation		usd
CY2023	MSSA	Initial Value Of Ordinary Stock Subject To Possible Redemptions InitialValueOfOrdinaryStockSubjectToPossibleRedemptions		usd
CY2023	MSSA	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares		usd
CY2023	MSSA	Change In Value Of Ordinary Shares Subject To Redemption ChangeInValueOfOrdinarySharesSubjectToRedemption		usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2023Q4	us-gaap	Cash Cash		usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2022Q4	MSSA	Deferred Underwriting Commissions Current DeferredUnderwritingCommissionsCurrent		usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2022	MSSA	Cash Withdrawn From Trust Account To Redeem Public Shares CashWithdrawnFromTrustAccountToRedeemPublicShares		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	36315397	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6407416	shares
CY2023	dei	Auditor Firm AuditorFirmId	1195
CY2023	dei	Auditor Name AuditorName	UHY LLP
CY2023	dei	Auditor Location AuditorLocation	Irvine, California
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	178652	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1875	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	39683	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1875	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	218335	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	35359088	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	116673481	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	35359088	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	116673481	usd
CY2023Q4	us-gaap	Assets Assets	35360963	usd
CY2022Q4	us-gaap	Assets Assets	116891816	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	298280	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146738	usd
CY2023Q4	MSSA	Due To Sponsor DueToSponsor	375834	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2846517	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	146738	usd
CY2023Q4	MSSA	Deferred Underwriting Commissions DeferredUnderwritingCommissions	2875000	usd
CY2022Q4	MSSA	Deferred Underwriting Commissions DeferredUnderwritingCommissions	2875000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2875000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2875000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5721517	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3021738	usd
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3202416	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11500000	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.21
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	35409088	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	116673481	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3205000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3205000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3205000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3205000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	3202416	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11500000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3205	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3205	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5772847	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2806608	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5769642	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2803403	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35360963	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116891816	usd
CY2023	MSSA	Formation And Operational Costs FormationAndOperationalCosts	798508	usd
CY2022	MSSA	Formation And Operational Costs FormationAndOperationalCosts	398812	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	798508	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	398812	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-398812	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	2794771	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	155897	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	377666	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2950668	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1673481	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2152160	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1274669	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2152160	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1274669	usd
CY2023	MSSA	Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedOnTrustAccount	-2950668	usd
CY2023	MSSA	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionAdditionalFundingForBusinessCombinationExtension	-2167731	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2152160	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5769642	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	150	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	115000000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-5175000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	529741	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3300000	usd
CY2022	MSSA	Stock Issued During Period Value Initial Value Of Ordinary Stock Subject To Possible Redemption StockIssuedDuringPeriodValueInitialValueOfOrdinaryStockSubjectToPossibleRedemption	-101200000	usd
CY2022	MSSA	Stock Issued During Period Value Allocation Of Offering Costs Related To Redeemable Shares StockIssuedDuringPeriodValueAllocationOfOfferingCostsRelatedToRedeemableShares	5020172	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-18820172	usd
CY2022	MSSA	Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedOnTrustAccount	-1673481	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1274669	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2803403	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2803403	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2152160	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1274669	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	2794771	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	1295815	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	155897	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	377666	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	100933	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	117817	usd
CY2022	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-236522	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	63125	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	157500	usd
CY2023	MSSA	Increase Decrease In Due To Sponsor IncreaseDecreaseInDueToSponsor	375834	usd
CY2022	MSSA	Increase Decrease In Accrued Offering Costs IncreaseDecreaseInAccruedOfferingCosts	-31550	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	151542	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	145938	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-233324	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87585	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2117731	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	115000000	usd
CY2023	MSSA	Cash Withdrawn From Trust Account To Redeem Public Shares CashWithdrawnFromTrustAccountToRedeemPublicShares	86382792	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	84265061	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115000000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	86382792	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2172403	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3300000	usd
CY2022	MSSA	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	114700000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2829741	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-84210389	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	115170259	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-178652	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	82674	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	178652	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	95978	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	178652	usd
CY2022	MSSA	Defer Underwriting Compensation DeferUnderwritingCompensation	2875000	usd
CY2022	MSSA	Initial Value Of Ordinary Stock Subject To Possible Redemptions InitialValueOfOrdinaryStockSubjectToPossibleRedemptions	101200000	usd
CY2022	MSSA	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares	-5020172	usd
CY2022	MSSA	Change In Value Of Ordinary Shares Subject To Redemption ChangeInValueOfOrdinarySharesSubjectToRedemption	18820172	usd
CY2023	MSSA	Subsequent Measurement Of Ordinary Shares Subject To Redemptions Interest Earned On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionsInterestEarnedOnTrustAccount	5118399	usd
CY2022	MSSA	Subsequent Measurement Of Ordinary Shares Subject To Redemptions Interest Earned On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionsInterestEarnedOnTrustAccount	1673481	usd
CY2022Q2	MSSA	Proceeds From Ipo And Private Placement ProceedsFromIpoAndPrivatePlacement	115682250	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	35359088	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	116673481	usd
CY2022Q2	MSSA	Proceeds From Ipo And Private Placement ProceedsFromIpoAndPrivatePlacement	115682250	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	178652	usd
CY2023Q4	MSSA	Working Capital WorkingCapital	-2844642	usd
CY2022Q4	MSSA	Working Capital WorkingCapital	71597	usd
CY2023Q4	MSSA	Working Capital WorkingCapital	-2844642	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	218335	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	116673481	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	116673481	usd
CY2022Q4	us-gaap	Assets Assets	116891816	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	146738	usd
CY2022Q4	MSSA	Deferred Underwriting Commissions Non Current DeferredUnderwritingCommissionsNonCurrent	2875000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2875000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3021738	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_z6KK7qCJ369e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zVClvCwaYSGa">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	178652	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2950668	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2794771	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	155897	usd
CY2023	MSSA	Cash Withdrawn From Trust Account To Redeem Public Shares CashWithdrawnFromTrustAccountToRedeemPublicShares	86382792	usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	8297584	shares
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1673481	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1295815	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	377666	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q3	MSSA	Share Repurchase Program Excise Tax Percentage ShareRepurchaseProgramExciseTaxPercentage	0.01	pure
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	2436497	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5915000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2152160	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1274669	usd
CY2023	MSSA	Remeasurement To Redemption Value RemeasurementToRedemptionValue	2167731	usd
CY2022	MSSA	Remeasurement To Redemption Value RemeasurementToRedemptionValue	18820172	usd
CY2023	MSSA	Interest And Dividends Earned In Trust Account To Be Allocated To Redeemable Shares InterestAndDividendsEarnedInTrustAccountToBeAllocatedToRedeemableShares	2950668	usd
CY2022	MSSA	Interest And Dividends Earned In Trust Account To Be Allocated To Redeemable Shares InterestAndDividendsEarnedInTrustAccountToBeAllocatedToRedeemableShares	1673481	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2966239	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19218984	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zTpvtGinDlS7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zdBnedcDjrp7">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5885324	shares
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.033
CY2023Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2412260	shares
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	115000000	usd
CY2023	MSSA	Proceeds Allocated To Public Rights ProceedsAllocatedToPublicRights	8510000	usd
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5290000	usd
CY2023	MSSA	Allocation Of Offering Costs Related To Ordinary Shares AllocationOfOfferingCostsRelatedToOrdinaryShares	5020172	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	86382792	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	20987903	usd
CY2023	MSSA	Subsequent Measurement Of Class Ordinary Shares Subject To Possible Redemption Interest Earned On Trust Account SubsequentMeasurementOfClassOrdinarySharesSubjectToPossibleRedemptionInterestEarnedOnTrustAccount	4624149	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	35409088	usd
CY2023Q1	MSSA	Payment Of Extesnsion Fee PaymentOfExtesnsionFee	383333	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.033
CY2023Q1	MSSA	Payment For Extension Fee PaymentForExtensionFee	187155	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	5885324	shares
CY2023Q4	MSSA	Payment For Extension Fee PaymentForExtensionFee	105680	usd
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.033
CY2023Q4	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	2412260	shares
CY2023Q4	MSSA	Deferred Underwriting Commission DeferredUnderwritingCommission	2875000	usd
CY2022Q4	MSSA	Deferred Underwriting Commission DeferredUnderwritingCommission	2875000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	25000	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	150000	usd
CY2023	MSSA	Monthly Payment Description MonthlyPaymentDescription	The Company entered into the agreement with a retainer of $5,000 per month starting from April 1, 2022
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	120000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	45000	usd
CY2024Q1	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	245000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3205000	shares
CY2022Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11500000	shares

Files In Submission

Name	View Source	Status
0001493152-24-034449-index-headers.html	Edgar Link	pending
0001493152-24-034449-index.html	Edgar Link	pending
0001493152-24-034449.txt	Edgar Link	pending
0001493152-24-034449-xbrl.zip	Edgar Link	pending
ex21.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mssa-20231231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mssa-20231231_cal.xml	Edgar Link	unprocessable
mssa-20231231_def.xml	Edgar Link	unprocessable
mssa-20231231_lab.xml	Edgar Link	unprocessable
mssa-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MSSA
Metal Sky Star Acquisition Corp Stock $mssa

2024 Q1 Form 10-K Financial Statement

#000149315224034449 Filed on August 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MSSA Metal Sky Star Acquisition Corp Stock $mssa

2024 Q1 Form 10-K Financial Statement

#000149315224034449 Filed on August 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MSSA
Metal Sky Star Acquisition Corp Stock $mssa